These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Diminished cytokine and chemokine expression in the central nervous system of GMF-deficient mice with experimental autoimmune encephalomyelitis. Zaheer A; Sahu SK; Wu Y; Zaheer A; Haas J; Lee K; Yang B Brain Res; 2007 May; 1144():239-47. PubMed ID: 17316572 [TBL] [Abstract][Full Text] [Related]
4. Suppression of neuro inflammation in experimental autoimmune encephalomyelitis by glia maturation factor antibody. Zaheer S; Wu Y; Sahu SK; Zaheer A Brain Res; 2011 Feb; 1373():230-9. PubMed ID: 21146509 [TBL] [Abstract][Full Text] [Related]
5. Glia maturation factor regulation of STAT expression: a novel mechanism in experimental autoimmune encephalomyelitis. Zaheer S; Wu Y; Bassett J; Yang B; Zaheer A Neurochem Res; 2007 Dec; 32(12):2123-31. PubMed ID: 17551829 [TBL] [Abstract][Full Text] [Related]
6. VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage. Abad C; Jayaram B; Becquet L; Wang Y; O'Dorisio MS; Waschek JA; Tan YV J Neuroinflammation; 2016 Jun; 13(1):169. PubMed ID: 27357191 [TBL] [Abstract][Full Text] [Related]
7. Diminished degradation of myelin basic protein by anti-sulfatide antibody and interferon-gamma in myelin from glia maturation factor-deficient mice. Menon K; Wu Y; Haas J; Sahu SK; Yang B; Zaheer A Neurosci Res; 2007 Jun; 58(2):156-63. PubMed ID: 17383764 [TBL] [Abstract][Full Text] [Related]
8. Tyrosine kinase 2 plays critical roles in the pathogenic CD4 T cell responses for the development of experimental autoimmune encephalomyelitis. Oyamada A; Ikebe H; Itsumi M; Saiwai H; Okada S; Shimoda K; Iwakura Y; Nakayama KI; Iwamoto Y; Yoshikai Y; Yamada H J Immunol; 2009 Dec; 183(11):7539-46. PubMed ID: 19917699 [TBL] [Abstract][Full Text] [Related]
9. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein. Lyons JA; Ramsbottom MJ; Cross AH Eur J Immunol; 2002 Jul; 32(7):1905-13. PubMed ID: 12115610 [TBL] [Abstract][Full Text] [Related]
10. Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice. Oliver AR; Lyon GM; Ruddle NH J Immunol; 2003 Jul; 171(1):462-8. PubMed ID: 12817031 [TBL] [Abstract][Full Text] [Related]
11. IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glucoprotein 35-55 induced experimental autoimmune encephalomyelitis. Okuda Y; Sakoda S; Fujimura H; Saeki Y; Kishimoto T; Yanagihara T J Neuroimmunol; 1999 Nov; 101(2):188-96. PubMed ID: 10580801 [TBL] [Abstract][Full Text] [Related]
12. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. Gran B; Zhang GX; Yu S; Li J; Chen XH; Ventura ES; Kamoun M; Rostami A J Immunol; 2002 Dec; 169(12):7104-10. PubMed ID: 12471147 [TBL] [Abstract][Full Text] [Related]
13. Kinin B2 receptor regulates chemokines CCL2 and CCL5 expression and modulates leukocyte recruitment and pathology in experimental autoimmune encephalomyelitis (EAE) in mice. Dos Santos AC; Roffê E; Arantes RM; Juliano L; Pesquero JL; Pesquero JB; Bader M; Teixeira MM; Carvalho-Tavares J J Neuroinflammation; 2008 Nov; 5():49. PubMed ID: 18986535 [TBL] [Abstract][Full Text] [Related]
14. Reduced severity of experimental autoimmune encephalomyelitis in GMF-deficient mice. Zaheer A; Zaheer S; Sahu SK; Yang B; Lim R Neurochem Res; 2007 Jan; 32(1):39-47. PubMed ID: 17151915 [TBL] [Abstract][Full Text] [Related]
15. Increased severity of experimental allergic encephalomyelitis in lyn-/- mice in the absence of elevated proinflammatory cytokine response in the central nervous system. Du C; Sriram S J Immunol; 2002 Mar; 168(6):3105-12. PubMed ID: 11884485 [TBL] [Abstract][Full Text] [Related]
16. Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis. Larabee CM; Desai S; Agasing A; Georgescu C; Wren JD; Axtell RC; Plafker SM Mol Vis; 2016; 22():1503-1513. PubMed ID: 28050123 [TBL] [Abstract][Full Text] [Related]
17. Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice. Vandenbark AA; Rich C; Mooney J; Zamora A; Wang C; Huan J; Fugger L; Offner H; Jones R; Burrows GG J Immunol; 2003 Jul; 171(1):127-33. PubMed ID: 12816990 [TBL] [Abstract][Full Text] [Related]
18. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells. Chung CY; Liao F J Neuroinflammation; 2016 Apr; 13(1):76. PubMed ID: 27068264 [TBL] [Abstract][Full Text] [Related]